FDA panel's support for Novartis drug could clear way for generic biotech in US
Federal health experts have unanimously endorsed a Novartis drug that is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market.
Arena Pharma climbs on positive data from early study of autoimmune disease drug ADP334
Shares of Arena Pharmaceuticals surged Wednesday after the drugmaker reported positive results from an early clinical trial of a possible treatment for autoimmune diseases.
General Motors recalling 92,221 full-size trucks, SUVs for heat-related ignition lock defect
General Motors is recalling 92,221 full-size trucks and SUVs for a defect in ignition lock systems that can cause safety problems in hot conditions.
Meadowbrook, NephroGenex, Chevron, RedHill Biopharma and Tekmira are big market movers
Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Meadowbrook Insurance Group Inc. (MIG), up $1.33 to $8.46 China's Fosun International investment group will buy the commercial insurance underwriter at a premium for about $433 million.
Automaker Volkswagen recalls 38,000 cars due to fire risk caused by a fuel leak
The Volkswagen Group of America is recalling about 38,000 cars because a fuel leak in the engine may cause a fire.
Chrysler recalls 67,000 pickup trucks, says ignition switch problem is linked to 1 death
Fiat Chrysler is recalling about 67,000 model year 2006 and 2007 pickups because of a problem that could prevent the cars from starting, or cause them to move when the ignition key is turned.
Recalls this week include Keurig coffee brewing systems, sweatshirts
A line of Keurig coffee brewers that can overheat and spray hot water are among this week's recalled consumer products.
For auto industry, recalling cars globally is much harder than making, selling them
When it comes to making and selling cars, the auto industry thinks and acts globally: There is near-seamless coordination between parts suppliers, factories and dealerships.
Firm recalls caramel apples amid fears of listeria linked to deaths or illnesses in 10 states
A Missouri firm is recalling its Happy Apple brand caramel apples because of the potential that they could be contaminated with listeria.
Automaker Honda recalls 1,252 Crosstour vehicles due to faulty side air bags
Honda is recalling 1,252 Crosstour vehicles due to a faulty side air bag made by troubled air bag supplier Takata.
Keurig recalls its 'Mini Plus' single-serve coffee makers because of reported burn injuries
Keurig is recalling some 7 million of single-serve coffee brewing machines because of reported burns.
FDA approves Novo Nordisk's Saxenda, an injectable weight-loss treatment
The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity.
FDA grants accelerated approval to Bristol-Myers drug for hard-to-treat melanoma
The Food and Drug Administration has approved a new drug from Bristol-Myers Squibb to treat the deadliest form of skin cancer.
BMW expands air bag recall nationwide; last automaker to agree to gov't demand to do so
BMW has agreed to demands from the government to expand a recall of driver's-side air bags to the entire U.S.
BioCryst Pharma says FDA approved its drug Rapivab, an oral treatment for influenza
BioCryst Pharmaceuticals said Monday that U.S. regulators approved its drug Rapivab, an intravenous treatment for the flu.
US says traffic deaths fell about 3 percent last year, but big truck crash deaths are rising
The number of traffic deaths nationwide dropped just over 3 percent last year, and the rate of deaths per 100 million miles traveled tied a record low, according to government statistics.
FDA OKs Cubist antibiotic for complex abdominal, urinary tract infections
The Food and Drug Administration has approved a new combination medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved this year.
FDA OKs AstraZeneca 's first-in-class ovarian cancer drug plus companion test from Myriad
U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC.
FDA OKs AstraZeneca 's first-in-class ovarian cancer drug, plus companion test from Myriad
U.S. regulators have granted accelerated approval to the first in a new class of drugs for ovarian cancer, AstraZeneca PLC's Lynparza.
FDA approves AbbVie combo hepatitis C treatment, part of wave of better, less-toxic options
Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.